Table 2 Subgroup analysis of effects of BRAF mutation on aggressive clinicopathological features and poor prognosis of PTC according to ethnics
Subgroup | OR | OR (95Â % CI) | I 2 (%) | Model used |
|---|---|---|---|---|
Extrathyroidal invasion | ||||
Asian (23 studies) | 1.84 | 1.53–2.22 | 58 | Random-effects |
Caucasian (26 studies) | 1.19 | 1.69–2.84 | 74 | Random-effects |
TNM stage | ||||
Asian (20 studies) | 1.69 | 1.34–2.14 | 56 | Random-effects |
Caucasian (30 studies) | 1.72 | 1.28–2.32 | 78 | Random-effects |
Lymph node metastasis | ||||
Asian (27 studies) | 1.25 | 1.06–1.49 | 58 | Random-effects |
Caucasian (30 studies) | 1.54 | 1.19–1.98 | 77 | Random-effects |
Recurrence | ||||
Asian (6 studies) | 1.30 | 1.01–1.68 | 80 | Random-effects |
Caucasian (18 studies) | 2.48 | 2.06–2.98 | 73 | Random-effects |